ADARx Pharmaceuticals

About:

ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.

Top Investors: BlackRock, OrbiMed, Invus, Bain Capital Life Sciences, Cormorant Asset Management

Description:

ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts. It discovers and develops innovative therapeutics that can utilize a family of endogenous enzymes called adenosine deaminase acting on RNA (ADAR) to precisely target and correct single point mutations on an mRNA, thus the production of desired and functional protein is restored.

Total Funding Amount:

$332M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)adarx.com

Founders:

Zhen Li